U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Breast large cell neuroendocrine carcinoma

MedGen UID:
307310
•Concept ID:
C1511316
•
Neoplastic Process
Synonyms: Breast Large Cell Neuroendocrine Carcinoma; breast large cell neuroendocrine carcinoma; large cell neuroendocrine carcinoma of breast
 
Monarch Initiative: MONDO:0003959

Definition

A poorly differentiated neuroendocrine carcinoma that arises from the breast. It is characterized by the presence of large neuroendocrine cells and high mitotic activity. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVBreast large cell neuroendocrine carcinoma

Professional guidelines

PubMed

Multidisciplinary Management of Orbital Metastasis and Survival Outcomes.
El-Hadad C, Koka K, Dong W, Do T, Haider M, Ursua JD, Ning J, Debnam JM, Esmaeli B
Ophthalmic Plast Reconstr Surg 2021 Nov-Dec 01;37(6):541-545. doi: 10.1097/IOP.0000000000001939. PMID: 33587417
Superficial Ewing's sarcoma family of tumors: a clinicopathological study with differential diagnoses.
Machado I, Llombart B, Calabuig-Fariñas S, Llombart-Bosch A
J Cutan Pathol 2011 Aug;38(8):636-43. Epub 2011 Jun 7 doi: 10.1111/j.1600-0560.2011.01705.x. PMID: 21649689
Regional treatment of hepatic metastases and hepatocellular carcinoma.
Kemeny N, Schneider A
Curr Probl Cancer 1989 Jul-Aug;13(4):197-283. doi: 10.1016/0147-0272(89)90007-x. PMID: 2548812

Recent clinical studies

Etiology

Neuroendocrine Neoplasms of the Breast: Current Insights and Future Directions.
Jiang L, Pan X, Lang Z
Cancer Rep (Hoboken) 2024 Nov;7(11):e70059. doi: 10.1002/cnr2.70059. PMID: 39585672Free PMC Article
Analysis of 25 surgical cases of thymic neuroendocrine tumors and thymic carcinoma.
Midorikawa K, Miyahara S, Nishino N, Ueda Y, Waseda R, Shiraishi T, Sato T
J Cardiothorac Surg 2024 Apr 16;19(1):225. doi: 10.1186/s13019-024-02723-w. PMID: 38627811Free PMC Article
Neuroendocrine neoplasms of the breast: diagnostic agreement and impact on outcome.
Metovic J, Cascardi E, Uccella S, Maragliano R, Querzoli G, Osella-Abate S, Pittaro A, La Rosa S, Bogina G, Cassoni P, Marchiò C, Sapino A, Castellano I, Papotti M
Virchows Arch 2022 Dec;481(6):839-846. Epub 2022 Oct 15 doi: 10.1007/s00428-022-03426-0. PMID: 36243799Free PMC Article
Lorlatinib and compound mutations in ALK+ large-cell neuroendocrine lung carcinoma: a case report.
Wiedemann C, Kazdal D, Cvetkovic J, Kunz J, Fisch D, Kirchner M, Kriegsmann M, Sültmann H, Heussel CP, Bischoff H, Thomas M, Stenzinger A, Christopoulos P
Cold Spring Harb Mol Case Stud 2022 Oct;8(6) Epub 2022 Oct 28 doi: 10.1101/mcs.a006234. PMID: 36207130Free PMC Article
Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group.
Mosele F, Remon J, Mateo J, Westphalen CB, Barlesi F, Lolkema MP, Normanno N, Scarpa A, Robson M, Meric-Bernstam F, Wagle N, Stenzinger A, Bonastre J, Bayle A, Michiels S, Bièche I, Rouleau E, Jezdic S, Douillard JY, Reis-Filho JS, Dienstmann R, André F
Ann Oncol 2020 Nov;31(11):1491-1505. Epub 2020 Aug 24 doi: 10.1016/j.annonc.2020.07.014. PMID: 32853681

Diagnosis

Neuroendocrine Neoplasms of the Breast: Current Insights and Future Directions.
Jiang L, Pan X, Lang Z
Cancer Rep (Hoboken) 2024 Nov;7(11):e70059. doi: 10.1002/cnr2.70059. PMID: 39585672Free PMC Article
Neuroendocrine neoplasms of the breast: diagnostic agreement and impact on outcome.
Metovic J, Cascardi E, Uccella S, Maragliano R, Querzoli G, Osella-Abate S, Pittaro A, La Rosa S, Bogina G, Cassoni P, Marchiò C, Sapino A, Castellano I, Papotti M
Virchows Arch 2022 Dec;481(6):839-846. Epub 2022 Oct 15 doi: 10.1007/s00428-022-03426-0. PMID: 36243799Free PMC Article
Asymptomatic Infiltrated Erythematous Skin Patch on the Breast.
Zanelli M, Zizzo M, Ascani S
JAMA Dermatol 2019 Dec 1;155(12):1420-1421. doi: 10.1001/jamadermatol.2019.3273. PMID: 31693054
Metastatic non-small cell lung carcinoma a mimic of primary breast carcinoma-case series and literature review.
Ali RH, Taraboanta C, Mohammad T, Hayes MM, Ionescu DN
Virchows Arch 2018 May;472(5):771-777. Epub 2017 Nov 5 doi: 10.1007/s00428-017-2262-4. PMID: 29105026
Primary neuroendocrine breast cancer, how much do we know so far?
Alkaied H, Harris K, Azab B, Dai Q
Med Oncol 2012 Dec;29(4):2613-8. Epub 2012 Apr 1 doi: 10.1007/s12032-012-0222-z. PMID: 22467078

Therapy

Lorlatinib and compound mutations in ALK+ large-cell neuroendocrine lung carcinoma: a case report.
Wiedemann C, Kazdal D, Cvetkovic J, Kunz J, Fisch D, Kirchner M, Kriegsmann M, Sültmann H, Heussel CP, Bischoff H, Thomas M, Stenzinger A, Christopoulos P
Cold Spring Harb Mol Case Stud 2022 Oct;8(6) Epub 2022 Oct 28 doi: 10.1101/mcs.a006234. PMID: 36207130Free PMC Article
Post-Radiation Grade 3 Neuroendocrine Carcinoma: A New Entity?
Hadoux J, Blanchard P, Scoazec JY, Burtin P, Planchard D, Malka D, Berdelou A, Boige V, Duvillard P, Leboulleux S, Faron M, Tselikas L, Deutsch E, Ducreux M, Baudin E
Neuroendocrinology 2021;111(1-2):139-145. Epub 2019 Oct 22 doi: 10.1159/000504255. PMID: 31639792
Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group.
Mosele F, Remon J, Mateo J, Westphalen CB, Barlesi F, Lolkema MP, Normanno N, Scarpa A, Robson M, Meric-Bernstam F, Wagle N, Stenzinger A, Bonastre J, Bayle A, Michiels S, Bièche I, Rouleau E, Jezdic S, Douillard JY, Reis-Filho JS, Dienstmann R, André F
Ann Oncol 2020 Nov;31(11):1491-1505. Epub 2020 Aug 24 doi: 10.1016/j.annonc.2020.07.014. PMID: 32853681
A case of large-cell neuroendocrine carcinoma harboring an EML4-ALK rearrangement with resistance to the ALK inhibitor crizotinib.
Omachi N, Shimizu S, Kawaguchi T, Tezuka K, Kanazu M, Tamiya A, Asami K, Okishio K, Kitaichi M, Atagi S
J Thorac Oncol 2014 Jun;9(6):e40-2. doi: 10.1097/JTO.0000000000000103. PMID: 24828670
Primary neuroendocrine breast cancer, how much do we know so far?
Alkaied H, Harris K, Azab B, Dai Q
Med Oncol 2012 Dec;29(4):2613-8. Epub 2012 Apr 1 doi: 10.1007/s12032-012-0222-z. PMID: 22467078

Prognosis

Neuroendocrine Neoplasms of the Breast: Current Insights and Future Directions.
Jiang L, Pan X, Lang Z
Cancer Rep (Hoboken) 2024 Nov;7(11):e70059. doi: 10.1002/cnr2.70059. PMID: 39585672Free PMC Article
Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group.
Mosele F, Remon J, Mateo J, Westphalen CB, Barlesi F, Lolkema MP, Normanno N, Scarpa A, Robson M, Meric-Bernstam F, Wagle N, Stenzinger A, Bonastre J, Bayle A, Michiels S, Bièche I, Rouleau E, Jezdic S, Douillard JY, Reis-Filho JS, Dienstmann R, André F
Ann Oncol 2020 Nov;31(11):1491-1505. Epub 2020 Aug 24 doi: 10.1016/j.annonc.2020.07.014. PMID: 32853681
Asymptomatic Infiltrated Erythematous Skin Patch on the Breast.
Zanelli M, Zizzo M, Ascani S
JAMA Dermatol 2019 Dec 1;155(12):1420-1421. doi: 10.1001/jamadermatol.2019.3273. PMID: 31693054
Metastatic non-small cell lung carcinoma a mimic of primary breast carcinoma-case series and literature review.
Ali RH, Taraboanta C, Mohammad T, Hayes MM, Ionescu DN
Virchows Arch 2018 May;472(5):771-777. Epub 2017 Nov 5 doi: 10.1007/s00428-017-2262-4. PMID: 29105026
Primary neuroendocrine breast cancer, how much do we know so far?
Alkaied H, Harris K, Azab B, Dai Q
Med Oncol 2012 Dec;29(4):2613-8. Epub 2012 Apr 1 doi: 10.1007/s12032-012-0222-z. PMID: 22467078

Clinical prediction guides

Neuroendocrine neoplasms of the breast: diagnostic agreement and impact on outcome.
Metovic J, Cascardi E, Uccella S, Maragliano R, Querzoli G, Osella-Abate S, Pittaro A, La Rosa S, Bogina G, Cassoni P, Marchiò C, Sapino A, Castellano I, Papotti M
Virchows Arch 2022 Dec;481(6):839-846. Epub 2022 Oct 15 doi: 10.1007/s00428-022-03426-0. PMID: 36243799Free PMC Article
PAX8 Expression in Breast Cancer.
Lu S, Yakirevich E, Hart J, Wang L, Wang Y
Appl Immunohistochem Mol Morphol 2021 Apr 1;29(4):293-298. doi: 10.1097/PAI.0000000000000883. PMID: 33208672
Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group.
Mosele F, Remon J, Mateo J, Westphalen CB, Barlesi F, Lolkema MP, Normanno N, Scarpa A, Robson M, Meric-Bernstam F, Wagle N, Stenzinger A, Bonastre J, Bayle A, Michiels S, Bièche I, Rouleau E, Jezdic S, Douillard JY, Reis-Filho JS, Dienstmann R, André F
Ann Oncol 2020 Nov;31(11):1491-1505. Epub 2020 Aug 24 doi: 10.1016/j.annonc.2020.07.014. PMID: 32853681
Breast metastasis and lung large-cell neuroendocrine carcinoma: first clinical observation.
Papa A, Rossi L, Verrico M, Di Cristofano C, Moretti V, Strudel M, Zoratto F, Minozzi M, Tomao S
Clin Respir J 2017 Sep;11(5):574-578. Epub 2015 Oct 20 doi: 10.1111/crj.12385. PMID: 26365150
Primary neuroendocrine breast cancer, how much do we know so far?
Alkaied H, Harris K, Azab B, Dai Q
Med Oncol 2012 Dec;29(4):2613-8. Epub 2012 Apr 1 doi: 10.1007/s12032-012-0222-z. PMID: 22467078

Recent systematic reviews

Utility of KI-67 as a prognostic biomarker in pulmonary neuroendocrine neoplasms: a systematic review and meta-analysis.
Naheed S, Holden C, Tanno L, Pattini L, Pearce NW, Green B, Jaynes E, Cave J, Ottensmeier CH, Pelosi G
BMJ Open 2022 Mar 3;12(3):e041961. doi: 10.1136/bmjopen-2020-041961. PMID: 35241462Free PMC Article

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Reviews

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...